Select a Region North America

Meet EVERSANA at Asembia 2024

EVERSANA has rapidly grown our next generation commercialization services and created new solutions to improve: 

  • INNOVATION to expedite access to care with a direct-to-patient care model that integrates telehealth and provides a real-time verification of patients’ insurance benefits   
  • VISIBILITY into your patients’ journeys through the integration of our hub and field reimbursement specialist teams. (Yes, we’re on the frontline, talking with patients, providers and payers!) 
  • ONBOARDING through the latest in digital patient engagement, powered by advanced data, AI and ML technologies. (Let’s go beyond the buzz of “omnichannel”!) 
  • FINANCIAL PREDICTABILITY as we reduce abandonment with evolving co-pay and affordability strategies. (Are you on top of the changes?) 
  • DISTRIBUTION AGILITY for flexibility to increase efficiency, maximize investments and minimize risk on a product-by-product basis. (Are you in control?) 

If you’re interested in learning more about EVERSANA  – meet with one of our experts for Patient Services, Market Access, Channel Distribution

 


Read Our Latest Thinking on Key Industry Topics:


Learn More About EVERSANA:

PATIENT-CENTERED SERVICES 

At EVERSANA, our team of experts leverage technology and automation to reduce access and affordability barriers, simplify onboarding and get patients on therapy faster, ultimately reducing frustrations and driving therapy adoption. Our Patient Services team is surrounded by best-in-class Field Deployment, Agency, Channel Management and more to ensure a positive brand experience. Explore more: 

REINVENT COMMERCIALIZATION  

EVERSANA reinvented commercialization in the pharmaceutical space. We work with large pharma to optimize the last few years of established brands – making the most out of revenue potential. We work with emerging biotech to launch their first products – delivering unparalleled agility to navigate market complexities and drive down costs – up to 20% if they had to commercialize on their own.  

  • Operational Rigor 
  • Integrated Services  
  • Optimized by Analytics 

NEW MODELS FOR ONCOLOGY, RARE & HIGH SCIENCE BRANDS 

We understand the needs and sophistication of complex therapies. Our award-winning commercialization models were developed to be agile, flexible, cost effective and to lower the risk of uncertainty. They are digital first and powered by data, analytics and AI.  

  • Agility to pivot strategies without “change order” mentality 
  • Speed to market 
  • Risk management 
  • Owners maintain full value of their asset